Redmile Group LLC 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Redmile Group LLC | 1,283,735 3.800% |
-570,373 (-30.76%) |
Filing |
| 2023-02-14 4:25 pm Sale |
2022-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Redmile Group LLC | 1,854,108 5.900% |
-100,312 (-5.13%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Redmile Group LLC | 1,954,420 6.300% |
1,954,420 (New Position) |
Filing |